SecBot SecBot
SECBOTREPLAY Home › Report › ABBV

ABBV · The Illinois Appellate Court affirmed summary judgment for AbbVie in a…

Abbvie · COURT-RULING filed May 17, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 3/10

COURT-RULING filed May 17, 2026 at 20:00 ET

The Illinois Appellate Court affirmed summary judgment for AbbVie in a product liability case over its XEN gel stent. The plaintiff failed to provide expert testimony that a manufacturing defect caused his injuries, ending the litigation in AbbVie's favor.

  • Appellate court affirmed summary judgment for AbbVie in strict product liability action.
  • Plaintiff alleged XEN gel stent had chemical residue causing eye injuries but lacked expert causation evidence.
  • Non-precedential order under Illinois Supreme Court Rule 23(e)(1).
  • No damages awarded, no injunction, no class action.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access